Contineum Therapeutics, Inc. (CTNM)
17.04
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
17.04
0.00 (0.00%)
After-Hours: 18:10
Contineum Therapeutics Enterprise Value : 411.33M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 411.33M |
| August 24, 2026 | 395.53M |
| August 21, 2026 | 416.60M |
| August 20, 2026 | 372.59M |
| August 19, 2026 | 372.59M |
| August 18, 2026 | 315.42M |
| August 17, 2026 | 316.55M |
| August 14, 2026 | 303.76M |
| August 13, 2026 | 345.51M |
| August 12, 2026 | 333.47M |
| August 11, 2026 | 327.45M |
| August 10, 2026 | 315.04M |
| August 07, 2026 | 335.73M |
| August 06, 2026 | 347.39M |
| August 05, 2026 | 344.38M |
| August 04, 2026 | 368.08M |
| August 03, 2026 | 369.20M |
| July 31, 2026 | 352.65M |
| July 30, 2026 | 362.43M |
| July 29, 2026 | 310.90M |
| July 28, 2026 | 302.63M |
| July 27, 2026 | 291.34M |
| July 24, 2026 | 298.87M |
| July 23, 2026 | 310.53M |
| July 22, 2026 | 324.07M |
| Date | Value |
|---|---|
| July 21, 2026 | 292.85M |
| July 20, 2026 | 278.93M |
| July 17, 2026 | 305.26M |
| July 16, 2026 | 296.99M |
| July 15, 2026 | 320.31M |
| July 14, 2026 | 318.05M |
| July 13, 2026 | 319.93M |
| July 10, 2026 | 341.37M |
| July 09, 2026 | 351.15M |
| July 08, 2026 | 358.67M |
| July 07, 2026 | 317.67M |
| July 06, 2026 | 354.16M |
| July 02, 2026 | 337.99M |
| July 01, 2026 | 343.25M |
| June 30, 2026 | 386.51M |
| June 29, 2026 | 321.42M |
| June 26, 2026 | 291.14M |
| June 25, 2026 | 260.11M |
| June 24, 2026 | 239.92M |
| June 23, 2026 | 205.90M |
| June 22, 2026 | 195.06M |
| June 18, 2026 | 207.02M |
| June 17, 2026 | 215.24M |
| June 16, 2026 | 224.22M |
| June 15, 2026 | 236.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 14.68M |
| CNBX Pharmaceuticals, Inc. | 1.379M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 67.18M |
| Fulcrum Therapeutics, Inc. | -19.10M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.15M |
| Total Expenses (Quarterly) | 15.15M |
| EPS Diluted (Quarterly) | -0.4044 |
| Earnings Yield | -10.19% |
| Normalized Earnings Yield | -10.19 |